AIkido Pharma (AIKI) Financials

$3.80

$-0.11 (-2.81%)

As on 22-Feb-2023 09:30EDT

Market cap

$20 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	0.01	0.03	1.24
Cost of Revenue	--	--	--	--	--	2.06
Gross Profit	--	--	--	0.01	0.03	1.24
Operating Expenses	13.79	9.44	6.55	5.69	4.50	5.06
Operating Profit (EBIT)	-13.79	-9.44	-6.55	-5.69	-6.87	-3.82
Other Income	--	--	-5.79	1.50	--	0.52
Profit before Tax	-16.66	-7.17	-12.34	-4.18	1.73	-3.31
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-16.66	-7.17	-12.34	-4.18	1.73	-3.31
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-19.67	-7.17	-12.34	-4.18	1.73	-3.31

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	81.85	101.60	29.62	10.53	12.10	4.11
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.70	--	--	--	--	2.29
Current Liabilities	1.90	1.06	0.88	0.75	1.15	2.58
Total Liabilities	86.35	102.66	30.50	11.28	13.25	8.97

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	28.36	11.77	2.76	10.15	10.35	4.63
Current Assets	56.09	90.89	27.73	1.13	2.91	4.35
Total Assets	86.35	102.66	30.50	11.28	13.25	8.97
Total Debt*	0.74	--	--	--	--	0.05
Net Current Assets	54.19	89.83	26.85	0.38	1.75	1.77

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-6.60	-4.02	-3.02	-2.73	-3.27
Cash Flow from Investing Activities	--	-8.85	-24.96	1.26	-0.15	1.26
Cash from Financing Activities	--	78.30	31.61	1.84	2.70	2.07
Net Cash Inflow / Outflow	--	--	2.62	0.07	--	0.06

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-10.93	-61.45	-36.97	21.25	-68.17
ROE (%)	-16.75	-10.93	-61.45	-36.97	21.32	-70.16
ROA (%)	-17.25	-10.77	-59.06	-34.10	15.54	-32.65
EBIT Margin (%)	--	--	--	-46,477.78	6,167.86	-267.48
Net Margin (%)	--	--	213.04	-276.84	6,167.86	-188.70
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	-1.00	-0.68	-0.98	0.41
EBIT Growth (%)	-68.67	23.47	-194.93	-342.21	152.24	48.95
Net Profit Growth (%)	-230.90	41.87	-194.93	-342.21	152.24	48.95
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.25	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.57	10.74	2.23	0.23	-0.86	2.15
Close Price ($)	6.84	10.03	14.85	22.44	41.77	90.88
High Price ($)	16.58	43.35	93.84	64.91	157.09	308.34
Low Price ($)	4.30	9.72	7.92	16.95	35.77	57.79
Market Cap ($ Cr)	19.53	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	--	--	--	0.01
Short term debt to equity ratio	0.00	--	--	--	--	0.01
Current Ratio	29.54	85.66	31.62	1.51	2.52	1.69
Quick Ratio	29.54	--	--	--	--	--
Interest Coverage	-27.43	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	0.00	0.00	0.12
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	15.88
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.